Nicholas Benedict

Nicholas Benedict

Serial biotech entrepreneur with substantial track record in the pharma & biotech industries. Co-Founder and former CEO of Allecra Therapeutics, a German Biotech with Phase 3 asset.
As a Biotech leader, raised in total USD420m in multiple public and private funding rounds across 3 companies. Pharma General Management roles include Head Novartis Pharmaceuticals UK, Global Franchise Head for 6 Therapeutic Areas at Novartis Basel. Career has focused on launching and building companies, business units, franchises and brands across both USA and EU with key successes in anti-infectives and immunology.